VascuBio Innovation Inc. is a Toronto-based biotech startup developing next-generation organ-on-chip and biomarker-driven platforms to better model human biology and enable earlier disease detection. By combining microfluidics, 3D bioprinted tissues, and proteomic analysis with AI, we create more human-relevant systems for drug discovery, particularly in neurological diseases.

Our mission is to accelerate the development of safer, more effective therapies and diagnostics. We work with pharmaceutical companies, research institutions, and healthcare innovators to bring more predictive, scalable, and accessible solutions to both drug development and diagnostics.